Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

284637

Sigma-Aldrich

7-Aminoheptanoic acid

98%

Synonym(s):

7-Aminooenanthic acid

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
H2N(CH2)6CO2H
CAS Number:
929-17-9
Molecular Weight:
145.20
Beilstein:
906887
EC Number:
213-197-5
MDL number:
MFCD00008242
UNSPSC Code:
12352106
PubChem Substance ID:
24857170
NACRES:
NA.22

Quality Level

100

Assay

98%

form

powder

reaction suitability

reaction type: solution phase peptide synthesis

mp

192-195 °C (lit.)

application(s)

peptide synthesis

SMILES string

NCCCCCCC(O)=O

InChI

1S/C7H15NO2/c8-6-4-2-1-3-5-7(9)10/h1-6,8H2,(H,9,10)

InChI key

XDOLZJYETYVRKV-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Storage Class Code

11 - Combustible Solids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

284637-BULK:
284637-5G:
284637-VAR:
284637-1G:
284637-100MG:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
STBG9104
STBG3728V
STBD8490V
STBF3754V
STBC3981V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tomoyuki Sasaki et al.
Thrombosis research, 130(4), e222-e228 (2012-07-17)
Thrombin-activatable fibrinolysis inhibitor (TAFI) is a plasma zymogen that is activated by thrombin in plasma. In fibrinolytic processes, carboxy-terminal lysine (Lys) residues in partially degraded fibrin are important sites for plasminogen binding and activation, and an active form of TAFI
V S De Serrano et al.
Biochemistry, 31(47), 11698-11706 (1992-12-01)
The properties of the cationic locus within the recombinant (r) kringle 2 domain (residues 180-261) of tissue-type plasminogen activator ([K2tPA]) that are responsible for stabilization of its interaction with the carboxylate moiety of omega-amino acid ligands have been assessed by
Is there any need for a TAFI(a) inhibitor as thrombolytic drug?
Ellen Vercauteren et al.
Thrombosis research, 130(4), 574-575 (2012-07-31)
V S De Serrano et al.
Biochemistry, 32(14), 3540-3548 (1993-04-13)
The involvement of specific aspartic acid (D) and glutamic acid (E) residues of the recombinant (r) kringle 2 (K2) domain of tissue-type plasminogen activator (tPA) in stabilizing its interaction with omega-amino acid ligands has been assessed by examination of these
A A Ooka et al.
Biospectroscopy, 5(1), 9-17 (1999-04-29)
Surface enhanced Raman spectroscopy (SERS) was used to characterize a homologous series of alpha,omega-amino acids on colloidal gold and silver. Raman and SER spectra of the alpha,omega-amino acids, NH2(CH2)nCOOH (n = 3-7), are presented and analyzed, revealing the probable conformations
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service